Welcome to Antoxis
Antoxis is an Aberdeen-based biotechnology company taking a rational approach to the design and synthesis of targeted antioxidants.
Antoxis is focused on the development of new drugs to combat age related diseases such as diabetes, Parkinson’s, Alzheimer’s and stroke.
As part of its regenerative medicine programme, Antoxis collaborates with leading stem cell companies and academic groups to validate the use of its proprietary compound libraries in a variety of cell types, including neuronal and beta cells.
